Ublituximab: a new anti-CD20 agent for multiple sclerosis-MedSci.cn

Ublituximab: a new anti-CD20 agent for multiple sclerosis

Oh, J; Bar-Or, A

Oh, J (通讯作者)，Univ Toronto, St Michaels Hosp, Div Neurol, Dept Med, Toronto, ON M5B 1W8, Canada.;Oh, J (通讯作者)，Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA.

LANCET NEUROLOGY, 2022; 21 (12): 1070

科室
- - 订阅+
  - 更多科室
工具
服务